Open-Label Safety Extension Study of Avonex

NCT00915460 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

408

Enrollment

INDUSTRY

Sponsor class

Conditions

Multiple Sclerosis

Interventions

DRUG: Interferon beta-1a (Avonex)

Sponsor

Biogen